The Influence of Hypothyroid Metabolic Status on Blood Coagulation and the Acquired Von Willebrand Syndrome

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Sep 28

PMID 37762844

Authors

Manuela Andrea Hoffmann

Sarah N Knoll

Pia-Elisabeth Baque

Florian Rosar

Inge Scharrer

Stefan Reuss

Mathias Schreckenberger

Affiliations

Soon will be listed here.

Abstract

The intent of this prospective study aimed to identify the influence of hypothyroid metabolic status on the coagulation and fibrinolytic system and association with the acquired von Willebrand syndrome (VWS-ac). We compared 54 patients without substitution therapy after radical thyroidectomy with 58 control subjects without pathological thyroid-stimulating-hormone (TSH)-values. Patients with TSH > 17.5 mU/L over a period of >4 weeks were included. The control-collective was selected based on age and sex to match the patient-collective. The data were collected using laboratory coagulation tests and patient questionnaires; a bleeding score was determined. There were significant differences in the measurement of activated-partial-thromboplastin-time (aPTT/ = 0.009), coagulation-factor VIII ( < 0.001) and von-Willebrand-activity (VWF-ac/ = 0.004) between the patient and control groups. The patient cohort showed an increased aPTT and decreased factor VIII and VWF-ac. 29.7% of the patient-collective compared to 17.2% of the control subjects met the definition of VWS-Ac ( = 0.12). The bleeding score showed significantly more bleeding symptoms in patients with a laboratory constellation of VWS-ac (no family history; = 0.04). Our results suggest hypocoagulability in hypothyroid patients. Hypothyroidism appears to have a higher incidence of VWS-ac. The increased risk of bleeding complications in hypothyroid patients may be of relevant importance for the outcome, especially in the context of invasive interventions.

References

Simone J, Abildgaard C, Schulman I . Blood coagulation in thyroid dysfunction. N Engl J Med. 1965; 273(20):1057-61. DOI: 10.1056/NEJM196511112732001. View

Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z . Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood. 1984; 64(5):981-5. View

Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G . Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab. 2001; 86(2):732-7. DOI: 10.1210/jcem.86.2.7221. View

Bashir H, Bhat M, Farooq R, Majid S, Shoib S, Hamid R . Comparison of hematological parameters in untreated and treated subclinical hypothyroidism and primary hypothyroidism patients. Med J Islam Repub Iran. 2013; 26(4):172-8. PMC: 3562538. View

Xu Q, Wang Y, Shen X, Zhang Y, Fan Q, Zhang W . The Effect of Subclinical Hypothyroidism on Coagulation and fibrinolysis: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2022; 13:861746. PMC: 9099207. DOI: 10.3389/fendo.2022.861746. View

Franchini M, Lippi G, Manzato F, Vescovi P, Targher G . Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol. 2009; 162(3):439-51. DOI: 10.1530/EJE-09-0958. View

Rodeghiero F, Castaman G . Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol. 2001; 14(2):321-35. DOI: 10.1053/beha.2001.0136. View

Abdollahi M, Cushman M, Rosendaal F . Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89(3):493-8. View

Ordookhani A, Burman K . Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders. Int J Endocrinol Metab. 2017; 15(2):e42649. PMC: 5626118. DOI: 10.5812/ijem.42649. View

10.

Gluvic Z, Zafirovic S, Obradovic M, Sudar-Milovanovic E, Rizzo M, Isenovic E . Hypothyroidism and Risk of Cardiovascular Disease. Curr Pharm Des. 2022; 28(25):2065-2072. DOI: 10.2174/1381612828666220620160516. View

11.

Tosetto A, Castaman G, Rodeghiero F . Bleeders, bleeding rates, and bleeding score. J Thromb Haemost. 2013; 11 Suppl 1:142-50. DOI: 10.1111/jth.12248. View

12.

Filippi A, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G . A national survey on aspirin patterns of use and persistence in community outpatients in Italy. Eur J Cardiovasc Prev Rehabil. 2011; 18(5):695-703. DOI: 10.1177/1741826710397850. View

13.

Castaman G, Tosetto A, Federici A, Rodeghiero F . Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance. Thromb Haemost. 2011; 105(4):647-54. DOI: 10.1160/TH10-11-0697. View

14.

Rodeghiero F, Tosetto A, Abshire T, Arnold D, Coller B, James P . ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010; 8(9):2063-5. DOI: 10.1111/j.1538-7836.2010.03975.x. View

15.

. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice.... Lancet. 1998; 351(9098):233-41. View

16.

Inoue K, Ritz B, Brent G, Ebrahimi R, Rhee C, Leung A . Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. JAMA Netw Open. 2020; 3(2):e1920745. DOI: 10.1001/jamanetworkopen.2019.20745. View

17.

Lundgaard M, Carle A, Birgitte Christiansen U, Sorensen A, Kristensen S, Andersen S . Prolonged APTT and autoimmune overt hypothyroidism identified postpartum: a case report. Eur Thyroid J. 2022; 11(4). PMC: 9346323. DOI: 10.1530/ETJ-22-0109. View

18.

Castaman G, Federici A, Tosetto A, La Marca S, Stufano F, Mannucci P . Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients. J Thromb Haemost. 2012; 10(4):632-8. DOI: 10.1111/j.1538-7836.2012.04661.x. View

19.

Bano A, Chaker L, de Maat M, Atiq F, Kavousi M, Franco O . Thyroid Function and Cardiovascular Disease: The Mediating Role of Coagulation Factors. J Clin Endocrinol Metab. 2019; 104(8):3203-3212. DOI: 10.1210/jc.2019-00072. View

20.

Pamukcu B, Oflaz H, Onur I, Cimen A, Nisanci Y . Effect of cigarette smoking on platelet aggregation. Clin Appl Thromb Hemost. 2011; 17(6):E175-80. DOI: 10.1177/1076029610394440. View